Sung, H. et al., ‘Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries’, CA Cancer J Clin, 2021, <a href="https://doi.org/10.3322/caac.21660." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.3322/caac.21660.</a>
Schaffar, R. et al., ‘A Population-Based Cohort of Young Women Diagnosed with Breast Cancer in Geneva, Switzerland’, PLoS One 14, 2019, <a href="https://doi.org/10.1371/journal.pone.0222136." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1371/journal.pone.0222136.</a>
Johnson, R.H. et al., Breast cancer in adolescents and young adults. Pediatr Blood Cancer, 2018, 65:e27397, <a href="https://doi.org/10.1002/pbc.27397" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1002/pbc.27397</a>,
Rosenberg, S.M. et al., ‘BRCA1 and BRCA2 Mutation Testing in Young Women with Breast Cancer’, JAMA Oncol, no. 2, 2016, pp. 730–736, <a href="https://doi.org/10.1001/jamaoncol.2015.5941." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1001/jamaoncol.2015.5941.</a>
Walsh, S.M. et al., ‘Breast Cancer in Young Black Women’, Br J Surg, no. 107, 2020, pp. 677–686, <a href="https://doi.org/10.1002/bjs.11401." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1002/bjs.11401.</a>
Plichta, J.K. et al., ‘Breast Cancer Tumor Histopathology, Stage at Presentation, and Treatment in the Extremes of Age’, Breast Cancer Res Treat, no. 180, 2020, pp. 227–235, <a href="https://doi.org/10.1007/s10549-020-05542-4." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s10549-020-05542-4.</a>
Shoemaker, M.L. et al., ‘Differences in Breast Cancer Incidence among Young Women Aged 20–49 Years by Stage and Tumor Characteristics, Age, Race, and Ethnicity, 2004–2013’, Breast Cancer Res Treat, no. 169, 2018, pp. 595–606, <a href="https://doi.org/10.1007/s10549-018-4699-9." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s10549-018-4699-9.</a>
Ganz, P.A., Bower, J.E., Stanton, A.L., ‘Special Issues in Younger Women with Breast Cancer’, Adv Exp Med Biol, no. 862, 2015, pp. 9–21. <a href="https://doi.org/10.1007/978-3-319-16366-6_2." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/978-3-319-16366-6_2.</a>
Meresse, M. et al., ‘Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?’, Breast J, no. 23, 2017, pp. 256–266, <a href="https://doi.org/10.1111/tbj.12726." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1111/tbj.12726.</a>
Ward, S.E. et al., ‘Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data’, Clin Oncol, no. 31, 2019, pp. 444–452, <a href="https://doi.org/10.1016/j.clon.2019.03.005." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.clon.2019.03.005.</a>
Lee, C.S. et al., ‘Screening for Breast Cancer in Women Age 75 Years and Older’, Am J Roentgenol, no. 210, 2018, pp. 256–263, <a href="https://doi.org/10.2214/AJR.17.18705." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.2214/AJR.17.18705.</a>
Lodi, M et al., ‘Breast Cancer in Elderly Women and Altered Clinico-Pathological Characteristics: A Systematic Review’, Breast Cancer Res Treat, no. 166, 2017, pp. 657–668.
Bagegni, N.A., Peterson, L.L., ‘Age-Related Disparities in Older Women with Breast Cancer’, in Advances in Cancer Research, Academic Press Inc., 2020, pp. 23–56.
Grumpelt, A.M. et al., ‘Tumor Characteristics and Therapy of Elderly Patients with Breast Cancer’, J Cancer Res Clin Oncol, no. 142, 2016, pp. 1,109–1,116, <a href="https://doi.org/10.1007/s00432-015-2111-2." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s00432-015-2111-2.</a>
Herbst, A., Ingemarsson, I., ‘Intermittent Versus Continuous Electronic Monitoring in Labour: A Randomised Study’, BJOG An Int J Obstet Gynaecol, 1994, <a href="https://doi.org/10.1111/j.1471-0528.1994.tb13181.x." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1111/j.1471-0528.1994.tb13181.x.</a>
Schonberg, M.A. et al., ‘Developing a Patient Decision Aid for Women Aged 70 and Older with Early Stage, Estrogen Receptor Positive, HER2 Negative, Breast Cancer’, J Geriatr Oncol, no. 10, 2019, pp. 980–986, <a href="https://doi.org/10.1016/j.jgo.2019.05.004." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1016/j.jgo.2019.05.004.</a>
Jolly, T.A. et al., ‘Adjuvant Treatment for Older Women with Invasive Breast Cancer’, Women's Heal, no. 12, 2016, pp. 129–146, <a href="https://doi.org/10.2217/whe.15.92." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.2217/whe.15.92.</a>
Jeon, Y.W. et al., ‘Optimal Treatment of Breast Cancer in Women Older Than 75 Years: A Korea Breast Cancer Registry Analysis’, Breast Cancer Res Treat, no. 178, 2019, pp. 693–701, <a href="https://doi.org/10.1007/s10549-019-05426-2." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1007/s10549-019-05426-2.</a>
Gal, O. et al., ‘Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome’, Oncology, no. 94, 2018, pp. 31–38, <a href="https://doi.org/10.1159/000480087." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1159/000480087.</a>
Biganzoli, L. et al., ‘Management of Elderly Patients with Breast Cancer: Updated Recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)’, Lancet Oncol, 2012, p. 13, e148–e160.
Abdel-Razeq, H. et al., ‘Tumor Characteristics and Treatment Outcomes of Older Patients with Breast Cancer in Jordan’, BMC Womens Health, no. 20, 2020, p. 118, <a href="https://doi.org/10.1186/s12905-020-00981-z." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.1186/s12905-020-00981-z.</a>
Erić, I. et al., ‘Breast Cancer in Young Women: Pathologic and Immunohistochemical Features’, Acta Clin Croat, no. 57, 2018, pp. 497–502, <a href="https://doi.org/10.20471/acc.2018.57.03.13." target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">https://doi.org/10.20471/acc.2018.57.03.13.</a>
Baban, C.K., Devane, L., Geraghty, J., ‘Change of Paradigm in Treating Elderly with Breast Cancer: Are We Undertreating Elderly Patients?’, Ir J Med Sci, no. 188, 2019, pp. 379–388.
Agborbesong, O. et al., ‘Breast Cancer Treatment in the Elderly: Do Treatment Plans That Do Not Conform to NCCN Recommendations Lead to Worse Outcomes?’, American Journal of Surgery, 2020, pp. 381–384.